5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future

S Vodenkova, T Buchler, K Cervena… - Pharmacology & …, 2020 - Elsevier
Fluorouracil (5-FU) is an essential component of systemic chemotherapy for colorectal
cancer (CRC) in the palliative and adjuvant settings. Over the past four decades, several …

ROS generation and antioxidant defense systems in normal and malignant cells

AV Snezhkina, AV Kudryavtseva… - Oxidative medicine …, 2019 - Wiley Online Library
Reactive oxygen species (ROS) are by‐products of normal cell activity. They are produced
in many cellular compartments and play a major role in signaling pathways. Overproduction …

5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer

SM Alzahrani, HA Al Doghaither… - Oncology …, 2023 - spandidos-publications.com
Although 5-fluorouracil (5-FU)-based chemotherapy is the major treatment for colorectal
cancer, it has disadvantages such as systemic toxicity, lack of effectiveness and selectivity …

Role of cytokines and chemokines in angiogenesis in a tumor context

M Geindreau, M Bruchard, F Vegran - Cancers, 2022 - mdpi.com
Simple Summary Tumor growth in solid cancers requires adequate nutrient and oxygen
supply, provided by blood vessels created by angiogenesis. Numerous studies have …

Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications

H Song, D Liu, S Dong, L Zeng, Z Wu, P Zhao… - Signal transduction and …, 2020 - nature.com
Drug resistance is a major hurdle in cancer treatment and a key cause of poor prognosis.
Epitranscriptomics and epiproteomics are crucial in cell proliferation, migration, invasion …

Gender differences in oxidative stress in relation to cancer susceptibility and survival

A Allegra, S Caserta, S Genovese, G Pioggia… - Antioxidants, 2023 - mdpi.com
Genetic, developmental, biochemical, and environmental variables interact intricately to
produce sex differences. The significance of sex differences in cancer susceptibility is being …

[HTML][HTML] Tumor-associated macrophages (TAMs) as biomarkers for gastric cancer: A review

MR Räihä, PA Puolakkainen - Chronic diseases and translational medicine, 2018 - Elsevier
Gastric adenocarcinoma is one of the most common types of cancer worldwide, with an
incidence of a million new cases annually. In addition to having a high mortality rate due to …

Combination of T cell-redirecting bispecific antibody ERY974 and chemotherapy reciprocally enhances efficacy against non-inflamed tumours

Y Sano, Y Azuma, T Tsunenari, Y Kayukawa… - Nature …, 2022 - nature.com
Identifying a strategy with strong efficacy against non-inflamed tumours is vital in cancer
immune therapy. ERY974 is a humanized IgG4 bispecific T cell-redirecting antibody that …

SAMHD1 protects cancer cells from various nucleoside-based antimetabolites

N Herold, SG Rudd, K Sanjiv, J Kutzner, J Bladh… - Cell cycle, 2017 - Taylor & Francis
Recently, we demonstrated that sterile α motif and HD domain containing protein 1
(SAMHD1) is a major barrier in acute myelogenous leukemia (AML) cells to the cytotoxicity …

Design, synthesis, in-vitro thymidine phosphorylase inhibition, in-vivo antiangiogenic and in-silico studies of C-6 substituted dihydropyrimidines

F Iftikhar, F Yaqoob, N Tabassum, MS Jan, A Sadiq… - Bioorganic …, 2018 - Elsevier
Thymidine phosphorylase (TP) is an angiogenic enzyme. It plays an important role in
angiogenesis, tumour growth, invasion and metastasis. In current research work, we study …